We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
-6.47%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.69%
AUM
$14.1B
AUM Growth
-$2.27B
(-14%)
Cap. Flow
-$900M
Cap. Flow
% of AUM
-6.37%
Top 10 Holdings %
Top 10 Hldgs %
19.2%
Holding
310
New
28
Increased
101
Reduced
110
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$225M |
| 2 |
Lowe's Companies
LOW
|
+$182M |
| 3 |
Yum! Brands
YUM
|
+$171M |
| 4 |
Amazon
AMZN
|
+$143M |
| 5 |
Steris
STE
|
+$99.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$253M |
| 2 |
Citigroup
C
|
+$243M |
| 3 |
Viatris
VTRS
|
+$151M |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$150M |
| 5 |
Whirlpool
WHR
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.37% |
| 2 | Consumer Discretionary | 17.52% |
| 3 | Technology | 15.79% |
| 4 | Industrials | 11.57% |
| 5 | Communication Services | 10.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
ExxonMobil
XOM
$636B
| $1.08M | 0.01% |
14,526
| – | – |
|
227
Johnson & Johnson
JNJ
$619B
| $1.05M | 0.01% |
11,265
| – | – |
|
228
Merck
MRK
$317B
| $971K | 0.01% |
20,603
| – | – |
|
229
State Street SPDR S&P Regional Banking ETF
KRE
$4.64B
| $826K | 0.01% |
20,050
| – | – |
|
230
Northern Trust
NTRS
$33.8B
| $824K | 0.01% |
12,096
| – | – |
|
231
Packaging Corp of America
PKG
$22.7B
| $819K | 0.01% |
13,610
-174,005
| -93% | -$11.6M |
|
232
Estee Lauder
EL
$31.8B
| $801K | 0.01% |
9,925
-1,244,945
| -99% | -$104M |
|
233
IBM
IBM
$221B
| $767K | 0.01% |
5,531
-681,904
| -99% | -$101M |
|
234
Gogo Inc
GOGO
$481M
| $739K | 0.01% |
48,350
-738,940
| -94% | -$12.6M |
|
235
Liberty Global Class C
LBTYK
$3.52B
| $712K | 0.01% |
19,987
-1,101,328
| -98% | -$44.5M |
|
|
WCN
236
Waste Connections
WCN
$42.3B
| $710K | 0.01% |
21,938
-1,365
| -6% | -$44.1K |
|
|
BEAT
237
DELISTED
BioTelemetry, Inc.
BEAT
| $613K | ﹤0.01% |
+50,100
| New | +$639K |
|
|
CB
238
DELISTED
CHUBB CORPORATION
CB
| $586K | ﹤0.01% |
4,779
| – | – |
|
239
Super Micro Computer
SMCI
$19.6B
| $565K | ﹤0.01% |
+207,400
| New | +$552K |
|
240
Berkshire Hathaway Class B
BRK.B
$1.12T
| $549K | ﹤0.01% |
4,213
| – | – |
|
241
SLB Ltd
SLB
$76B
| $543K | ﹤0.01% |
7,874
-105
| -1% | -$8.31K |
|
242
Lindblad Expeditions
LIND
$2.2B
| $496K | ﹤0.01% |
50,800
| – | – |
|
|
ILG
243
DELISTED
ILG, Inc Common Stock
ILG
| $494K | ﹤0.01% |
26,900
| – | – |
|
244
Procter & Gamble
PG
$338B
| $486K | ﹤0.01% |
6,760
-97
| -1% | -$7.27K |
|
245
Idexx Laboratories
IDXX
$46.6B
| $475K | ﹤0.01% |
+6,400
| New | +$458K |
|
246
SouthState Bank Corp
SSB
$10.5B
| $438K | ﹤0.01% |
5,700
| – | – |
|
|
QTNT
247
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $431K | ﹤0.01% |
829
-41
| -5% | -$25.6K |
|
248
Air Products & Chemicals
APD
$67.2B
| $424K | ﹤0.01% |
3,589
| – | – |
|
249
Medtronic
MDT
$110B
| $420K | ﹤0.01% |
6,276
-74
| -1% | -$5.45K |
|
250
Coca-Cola
KO
$374B
| $410K | ﹤0.01% |
10,210
| – | – |
|
Similar funds
OAG
JG
CHP
SC
Westfield Capital Management's Q3 2015 Portfolio in Review
As of Q3 2015, Westfield Capital Management held 310 positions worth $14.1B, down 14% from $16.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Westfield Capital Management withdrew a net $900M in Q3 2015, closing 49 positions and reducing 110 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $150M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Westfield Capital Management opened a new position in Lowe's Companies worth $182M.
- Westfield Capital Management's largest Q3 2015 buy was Lowe's Companies: 2,647,293 shares worth $182M.
- Westfield Capital Management added most to Vertex Pharmaceuticals in Q3 2015, an estimated $225M increase.
- Westfield Capital Management's biggest Q3 2015 reduction was Allergan plc, cutting an estimated $253M.
- Westfield Capital Management fully exited PRECISION CASTPARTS CORP in Q3 2015, selling an estimated $150M.
- Westfield Capital Management's ten largest holdings make up 19% of its $14.1B portfolio in Q3 2015.
- Westfield Capital Management opened 28 new positions and closed 49 in Q3 2015.
- Westfield Capital Management's portfolio value fell 14% quarter-over-quarter to $14.1B.
Based on Westfield Capital Management's 13F filing for Q3 2015, filed 12 Nov 2015.